Amanote Research
Register
Sign In
Cost-Effectiveness of Antiviral Treatment After Resection in HBV-related Hepatocellular Carcinoma Patients With Compensated Cirrhosis
Hepatology
- United States
doi 10.1002/hep.29922
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Hepatology
Date
May 14, 2018
Authors
Li Xie
Juan Yin
Ruyi Xia
Guihua Zhuang
Publisher
Wiley
Related search
Cost Effectiveness of Alternative Surveillance Strategies for Hepatocellular Carcinoma in Patients With Cirrhosis
Clinical Gastroenterology and Hepatology
Hepatology
Gastroenterology
Effectiveness of Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis
Cancer Epidemiology Biomarkers and Prevention
Medicine
Epidemiology
Oncology
Effects of Antiviral Therapy on Post-Hepatectomy HBV Reactivation and Liver Function in HBV DNA-negative Patients With HBV-related Hepatocellular Carcinoma
Oncotarget
Oncology
HBV-DNA Load-Related Peritumoral Inflammation and ALBI Scores Predict HBV Associated Hepatocellular Carcinoma Prognosis After Curative Resection
Journal of Oncology
Oncology
Clinical Outcomes of Direct-Acting Antiviral Therapy in Patients With Compensated Hepatitis C Virus-Related Cirrhosis
Hepatoma Research
Treatment of Hepatocellular Carcinoma in Compensated Cirrhosis With Radio-Frequency Thermal Ablation (RFTA): A Prospective Study
Journal of Hepatology
Hepatology
Lower Effectiveness of Hepatitis C Antiviral Treatment in Patients With Hepatocellular Carcinoma: Is Active Tumor the Clue?
Hepatology
Medicine
Hepatology
Corrigendum to “Peritumoral EpCAM Is an Independent Prognostic Marker After Curative Resection of HBV-Related Hepatocellular Carcinoma”
Disease Markers
Biochemistry
Medicine
Clinical Biochemistry
Molecular Biology
Genetics
Lack of Reduction of Serum Alphafetoprotein During Treatment With Direct Antiviral Agents Predicts Hepatocellular Carcinoma Development in a Large Cohort of Patients With HCV-related Cirrhosis
Digestive and Liver Disease
Hepatology
Gastroenterology
